Tolterodine is a benzhydryl compound and a muscarinic receptor antagonist possessing both antimuscarinic and antispasmodic properties. Both tolterodine and its active metabolite, 5-hydroxymethyl tolterodine, competitively blocks muscarinic receptors, thereby inhibiting acetylcholine binding. This antagonistic action results in an increase in residual urine, reflecting an incomplete emptying of the bladder, and a decrease in detrusor pressure, indicating an antimuscarinic action on the lower urinary tract. The 5-hydroxymethyl metabolite appears to contribute significantly to the therapeutic effects.
Tolterodine is an antimuscarinic drug that is used for symptomatic treatment of urinary incontinence. This medication is used to treat an overactive bladder. By relaxing the muscles in the bladder, tolterodine improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
Mechanism of Action of Tolterodine
Both tolterodine and its active metabolite, 5-hydroxymethyl tolterodine, act as competitive antagonists at muscarinic receptors. This antagonism results in inhibition of bladder contraction, a decrease in detrusor pressure, and an incomplete emptying of the bladder.nBoth urinary bladder contraction and salivation are mediated via cholinergic muscarinic receptors. After oral administration, tolterodine is metabolized in the liver, resulting in the formation of the 5-hydroxymethyl derivative, a major pharmacologically active metabolite. The 5-hydroxymethyl metabolite, which exhibits an antimuscarinic activity similar to that of tolterodine, contributes significantly to the therapeutic effect. Both tolterodine and the 5-hydroxymethyl metabolite exhibit a high specificity for muscarinic receptors, since both show negligible activity or affinity for other neurotransmitter receptors and other potential cellular targets, such as calcium channels. Tolterodine has a pronounced effect on bladder function. The main effects of tolterodine are an increase in residual urine, reflecting an incomplete emptying of the bladder, and a decrease in detrusor pressure, consistent with an antimuscarinic action on the lower urinary tract.
Indications of Tolterodine
- Overactive Bladder
- Urinary Incontinence
- Treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
- For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
Contra-Indications of Tolterodine
- Disorder of mental processes due to a brain disease
- Myasthenia gravis
- closed angle glaucoma
- Worsening of glaucoma
- Very rapid heartbeat – torsades de pointes
- prolonged QT interval on EKG
- Abnormal EKG with QT changes from birth
- Narrowing of the opening between the stomach and small intestine
- severe liver disease
- severe renal impairment
- Blockage of urinary bladder
- Cannot empty bladder
- Problem emptying stomach contents
- Decreased motility function of stomach or intestines
Dosages of Tolterodine
Strengths: 1 mg; 2 mg; 4 mg
Urinary Incontinence
Immediate release tablets
- Initial dose: 2 mg orally 2 times a day
- Maintenance dose: 1 to 2 mg orally 2 times a day, depending on patient response and tolerability
Extended release capsules
- Initial dose: 4 mg orally once a day
- Maintenance dose: 2 to 4 mg orally once a day, depending on patient response and tolerability
Urinary Frequency
Immediate release tablets
- Initial dose: 2 mg orally 2 times a day
- Maintenance dose: 1 to 2 mg orally 2 times a day, depending on patient response and tolerability
Extended release capsules
- Initial dose: 4 mg orally once a day
- Maintenance dose: 2 to 4 mg orally once a day, depending on patient response and tolerability
Side Effects of tolterodine
The most common
- xerostomia (dry mouth)
- decreased gastric motility (upset stomach)
- Headache
- constipation
- dry eyes
- sleepiness
- urinary retention
- chest pain, fast or uneven heart rate;
- confusion, hallucinations;
- urinating less than usual or not at all; or
- painful or difficult urination.
More common
- Abnormal vision, including difficulty with adjusting to distances
- bloody or cloudy urine
- difficult, burning, or painful urination
- frequent urge to urinate
- Sensation of pins and needles in the fingers and toes
- Allergic reactions
- Nervousness
- Aware of the heartbeat (palpitations)
- Heart failure
- Irregular heartbeat
- Heart burn
- Memory impairment
Less common
- Chest pain
- cough
- diarrhea
- fever
- general feeling of discomfort or illness
- headache
- joint pain
- loss of appetite
- muscle aches and pains
- nausea
- pain or tenderness around the eyes and cheekbones
- shortness of breath or troubled breathing
- sore throat
- stuffy or runny nose
- sweating
- the tightness of the chest or wheezing
- trouble with sleeping
Drug Interactions of tolterodine
Toltaradin may interact with following drugs, supplements & may change the efficacy of drugs
- arsenic trioxide
- chloroquine or halofantrine
- cyclosporine
- droperidol
- narcotic medication such as levomethadyl or methadone ;
- pentamidine
- antibiotics such as azithromycin , clarithromycin , erythromycin , or telithromycin ;
- medicines to treat psychiatric disorders, such as chlorpromazine , haloperidol mesoridazine pimozide , or thioridazine ; or
- heart rhythm medicine such as amiodarone , dofetilide , disopyramide , procainamide , quinidine , or sotalol .
Pregnancy & Lactation of tolterodine
FDA Pregnancy Category C
Pregnancy
You should not use Tolterodine tablets when you are pregnant. Tell your doctor immediately if you are pregnant, think you are pregnant or are planning to become pregnant.
Breast-feeding
It is not known if tolterodine is excreted in the mother’s breast milk. Breastfeeding is not recommended during administration of Tolterodine tablets.
References
About the author